AAAAAA

   
Results: 1-14 |
Results: 14
HEALTH-RELATED QUALITY-OF-LIFE ONE-YEAR AFTER ALLOGENEIC OR AUTOLOGOUS STEM-CELL TRANSPLANTATION - A DESCRIPTIVE, PROSPECTIVE ANALYSIS
Authors: HJERMSTAD MJ KVALOY SO EVENSEN SA FAYERS PM KAASA S
Citation: Mj. Hjermstad et al., HEALTH-RELATED QUALITY-OF-LIFE ONE-YEAR AFTER ALLOGENEIC OR AUTOLOGOUS STEM-CELL TRANSPLANTATION - A DESCRIPTIVE, PROSPECTIVE ANALYSIS, Psycho-oncology, 7(3), 1998, pp. 2133-2133
HEALTH-RELATED QUALITY-OF-LIFE ONE-YEAR AFTER BONE-MARROW OR STEM-CELL TRANSPLANTATION - A DESCRIPTIVE, PROSPECTIVE ANALYSIS
Authors: HJERMSTAD MJ KVALOY SO EVENSEN SA KAASA S
Citation: Mj. Hjermstad et al., HEALTH-RELATED QUALITY-OF-LIFE ONE-YEAR AFTER BONE-MARROW OR STEM-CELL TRANSPLANTATION - A DESCRIPTIVE, PROSPECTIVE ANALYSIS, Bone marrow transplantation, 21, 1998, pp. 554-554
OUTCOME OF A MULTICENTER TREATMENT PROGRAM INCLUDING AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR DE-NOVO ACUTE MYELOID-LEUKEMIA
Authors: WAHLIN A BRINCH L HORNSTEN P EVENSEN SA OBERG G SIMONSSON B HEDENUS M
Citation: A. Wahlin et al., OUTCOME OF A MULTICENTER TREATMENT PROGRAM INCLUDING AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR DE-NOVO ACUTE MYELOID-LEUKEMIA, European journal of haematology, 58(4), 1997, pp. 233-240
EUROPEAN RESULTS OF MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - IMPACT OF HLA CLASS-II MATCHING
Authors: DEVERGIE A APPERLEY JF LABOPIN M MADRIGAL A JACOBSEN N CARRERAS E PRENTICE HG JOUET JP KOLB HJ HERSTENSTEIN B BACIGALUPO A EVENSEN SA LJUNGMAN P DEWITTE T REIFFERS J NAGLER A CLARK RE GOLDMAN JM GRATWOHL A
Citation: A. Devergie et al., EUROPEAN RESULTS OF MATCHED UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - IMPACT OF HLA CLASS-II MATCHING, Bone marrow transplantation, 20(1), 1997, pp. 11-19
RESULTS OF A TREATMENT PROGRAM INCLUDING AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR DE-NOVO ACUTE MYELOID-LEUKEMIA (AML)
Authors: WAHLIN A BRINCH L HORNSTEN P EVENSEN SA OBERG G SIMONSSON B HEDENUS M
Citation: A. Wahlin et al., RESULTS OF A TREATMENT PROGRAM INCLUDING AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR DE-NOVO ACUTE MYELOID-LEUKEMIA (AML), Blood, 88(10), 1996, pp. 2442-2442
HEPATITIS-C VIRUS SEROCONVERSION IN A HEMOPHILIAC TREATED EXCLUSIVELYWITH SOLVENT DETERGENT-TREATED CLOTTING FACTOR CONCENTRATE
Authors: EVENSEN SA ROLLAG H GLOMSTEIN A
Citation: Sa. Evensen et al., HEPATITIS-C VIRUS SEROCONVERSION IN A HEMOPHILIAC TREATED EXCLUSIVELYWITH SOLVENT DETERGENT-TREATED CLOTTING FACTOR CONCENTRATE, European journal of clinical microbiology & infectious diseases, 14(7), 1995, pp. 631-632
DECREASED LUNG-FUNCTION IN ONE-YEAR SURVIVORS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION CONDITIONED WITH HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE
Authors: LUND MB KONGERUD J BRINCH L EVENSEN SA BOE J
Citation: Mb. Lund et al., DECREASED LUNG-FUNCTION IN ONE-YEAR SURVIVORS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION CONDITIONED WITH HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE, The European respiratory journal, 8(8), 1995, pp. 1269-1274
SUBCUTANEOUS INJECTIONS OF 2-CHLORODEOXYADENOSINE FOR SYMPTOMATIC HAIRY-CELL LEUKEMIA
Authors: JULIUSSON G HELDAL D HIPPE E HEDENUS M MALM C WALLMAN K STOLT CM EVENSEN SA ALBERTIONI F TJONNFJORD G LENKEI R LILIEMARK J
Citation: G. Juliusson et al., SUBCUTANEOUS INJECTIONS OF 2-CHLORODEOXYADENOSINE FOR SYMPTOMATIC HAIRY-CELL LEUKEMIA, Journal of clinical oncology, 13(4), 1995, pp. 989-995
SYNOVECTOMY FOR HEMOPHILIC ARTHROPATHY - 6-21 YEARS OF FOLLOW-UP IN 16 PATIENTS - REPLY
Authors: TJONNFJORD GE TEIGLAND JC EVENSEN SA
Citation: Ge. Tjonnfjord et al., SYNOVECTOMY FOR HEMOPHILIC ARTHROPATHY - 6-21 YEARS OF FOLLOW-UP IN 16 PATIENTS - REPLY, Journal of internal medicine, 236(4), 1994, pp. 480-481
SYNOVECTOMY FOR HEMOPHILIC ARTHROPATHY - 6-21 YEARS OF FOLLOW-UP IN 16 PATIENTS
Authors: TEIGLAND JC TJONNFJORD GE EVENSEN SA CHARANIA B
Citation: Jc. Teigland et al., SYNOVECTOMY FOR HEMOPHILIC ARTHROPATHY - 6-21 YEARS OF FOLLOW-UP IN 16 PATIENTS, Journal of internal medicine, 235(3), 1994, pp. 239-243
ESTIMATED 8-YEAR SURVIVAL OF MORE THAN 40-PERCENT IN A POPULATION-BASED STUDY OF 79 ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: EVENSEN SA BRINCH I TJONNFJORD G STAVEM P WISLOFF F
Citation: Sa. Evensen et al., ESTIMATED 8-YEAR SURVIVAL OF MORE THAN 40-PERCENT IN A POPULATION-BASED STUDY OF 79 ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 88(1), 1994, pp. 88-93
CHARACTERIZATION OF CD34-BLOOD CELLS FROM HEALTHY-ADULTS MOBILIZED BYRECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR( PERIPHERAL)
Authors: TJONNFJORD GE STEEN R EVENSEN SA THORSBY E EGELAND T
Citation: Ge. Tjonnfjord et al., CHARACTERIZATION OF CD34-BLOOD CELLS FROM HEALTHY-ADULTS MOBILIZED BYRECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR( PERIPHERAL), Blood, 84(8), 1994, pp. 2795-2801
INCREASING AGE AND SURVIVAL AFTER BONE-MARROW TRANSPLANT
Authors: BRINCH L EVENSEN SA ALBRECHTSEN D
Citation: L. Brinch et al., INCREASING AGE AND SURVIVAL AFTER BONE-MARROW TRANSPLANT, JAMA, the journal of the American Medical Association, 270(21), 1993, pp. 2560-2560
KNEE ARTHROPLASTY IN HEMOPHILIA - 5-12 YEAR FOLLOW-UP OF 15 PATIENTS
Authors: TEIGLAND JC TJONNFJORD GE EVENSEN SA CHARANIA B
Citation: Jc. Teigland et al., KNEE ARTHROPLASTY IN HEMOPHILIA - 5-12 YEAR FOLLOW-UP OF 15 PATIENTS, Acta orthopaedica Scandinavica, 64(2), 1993, pp. 153-156
Risultati: 1-14 |